A carregar...
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment
Despite the development of effective therapies, a substantial proportion of asthmatics continue to have uncontrolled symptoms, airflow limitation, and exacerbations. Transient receptor potential cation channel member A1 (TRPA1) agonists are elevated in human asthmatic airways, and in rodents, TRPA1...
Na minha lista:
| Publicado no: | J Exp Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Rockefeller University Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7918756/ https://ncbi.nlm.nih.gov/pubmed/33620419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20201637 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|